S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Your Money is Not Safe (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Top 5 AI Stocks to Buy for 2024 (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
The “Perfect Storm” for Gold (Ad)
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Your Money is Not Safe (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Top 5 AI Stocks to Buy for 2024 (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
The “Perfect Storm” for Gold (Ad)
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Your Money is Not Safe (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Top 5 AI Stocks to Buy for 2024 (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
The “Perfect Storm” for Gold (Ad)
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Your Money is Not Safe (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Top 5 AI Stocks to Buy for 2024 (Ad)
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
The “Perfect Storm” for Gold (Ad)
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
Free Trial
NYSE:ISR

Isoray (ISR) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free ISR Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.28
▼
$0.42
52-Week Range
N/A
Volume
145,000 shs
Average Volume
290,697 shs
Market Capitalization
$54.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ISR stock logo

About Isoray Stock (NYSE:ISR)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

ISR Stock News Headlines

November 22, 2023 | morningstar.com
French ISR Label Revamp Report
April 24, 2023 | thestreet.com
Why IsoRay (ISR) Is Plunging Today
April 16, 2024 | Manward Press (Ad)
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
March 16, 2023 | thestreet.com
Why IsoRay (ISR) Stock Is Surging Today
February 16, 2023 | finance.yahoo.com
IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates
February 16, 2023 | finance.yahoo.com
Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022
February 8, 2023 | finanznachrichten.de
Isoray, Inc.: Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.
February 7, 2023 | finance.yahoo.com
Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.
April 16, 2024 | Manward Press (Ad)
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
February 6, 2023 | finance.yahoo.com
Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine
January 30, 2023 | benzinga.com
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders
January 30, 2023 | finance.yahoo.com
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders
January 14, 2023 | thestreet.com
Why IsoRay (ISR) Hit a Five-Year High Today (Update)
January 12, 2023 | finance.yahoo.com
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023
December 14, 2022 | finance.yahoo.com
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022
December 14, 2022 | finance.yahoo.com
AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023
December 6, 2022 | proactiveinvestors.com
Isoray's merger with Viewpoint Molecular Targeting sets up big opportunity in 2023
December 6, 2022 | proactiveinvestors.com
Isoray releases Q1 financials as company looks ahead to merger with Viewpoint Molecular Targeting
November 25, 2022 | finance.yahoo.com
Isoray, Inc. (ISR) Stock Historical Prices & Data - Yahoo Finance
November 11, 2022 | finanznachrichten.de
Isoray, Inc.: Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger
November 10, 2022 | seekingalpha.com
Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript
November 10, 2022 | finance.yahoo.com
Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger
October 31, 2022 | finance.yahoo.com
Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
October 20, 2022 | seekingalpha.com
Isoray Stock: Not Going Anywhere Anytime Soon (NYSE:ISR) - Seeking Alpha
October 18, 2022 | businesswire.com
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT - Business Wire
October 18, 2022 | finance.yahoo.com
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT
October 16, 2022 | benzinga.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMBC, BTRS, ISR, JVA - Isoray (AMEX:ISR), BTRS H - Benzinga
See More Headlines
Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
4/16/2024
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSE:ISR
CUSIP
N/A
CIK
728387
Web
isoray.com
Phone
(509) 375-1202
Fax
509-267-3670
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,270,000.00
Net Margins
-115.91%
Pretax Margin
-91.45%
Return on Equity
-17.12%
Return on Assets
-16.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.38
Quick Ratio
13.99

Sales & Book Value

Annual Sales
$10.80 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.43 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
142,110,000
Free Float
138,674,000
Market Cap
$54.57 million
Optionable
Not Optionable
Beta
1.48
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Lori A. Woods
    Chief Executive Officer & Director
  • Jennifer Streeter
    Chief Operating Officer & VP-Human Resources
  • Mark J. Austin
    Co-CFO, Secretary & Chief Accounting Officer
  • Jonathan R. Hunt
    CFO & Principal Financial Officer
  • William A. Cavanagh
    Chief Research & Development Officer

Key Competitors

View All Competitors

ISR Stock Analysis - Frequently Asked Questions

How were Isoray's earnings last quarter?

Isoray, Inc. (NYSE:ISR) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The firm had revenue of $2.56 million for the quarter, compared to analysts' expectations of $2.58 million. Isoray had a negative trailing twelve-month return on equity of 17.12% and a negative net margin of 115.91%.

This page (NYSE:ISR) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Can't believe it's happening again
Manward Press
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How to Know Which AI Company to Invest In… and When
Banyan Hill Publishing
Options trading has suddenly become more reliable.
Eagle Publishing
The Greatest Bull Market in Crypto History…
Weiss Ratings